FDMT
4D Molecular Therapeutics Inc
14.50$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +78.8% | +0.0% | -51.3% | +0.0% | -75.5% | +275.9% | +74.1% | +2.8% | +104.3% | -113.2% | – | +629.0% | -90.6% | -93.3% | +1,225.0% | -86.7% | +208.6% | +149.4% | -76.1% | -19.8% | +8,353.6% | -100.1% | – | -82.1% | -40.0% | -66.7% | +1,300.0% | +7.1% | +500.0% | +94,444.4% | -96.4% | +24.1% | – | |
| – | +0.0% | +23.7% | +0.0% | +67.3% | +0.0% | +10.4% | +31.8% | +6.5% | +19.5% | -26.5% | +9.1% | +1.3% | +19.2% | +4.1% | +10.7% | +10.6% | +5.4% | -7.3% | +13.5% | +4.2% | +5.2% | +6.3% | +3.8% | +7.1% | +14.3% | +20.8% | -95.4% | +2,181.3% | +17.8% | -1.5% | -95.8% | +3.8% | +1.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -98.8% | +70.6% | – | |
| – | +0.0% | +23.7% | +0.0% | +67.3% | +0.0% | +10.4% | +31.8% | +6.5% | +19.5% | -26.5% | +9.1% | +1.3% | +19.2% | +4.1% | +10.7% | +10.6% | +5.4% | -7.3% | +13.5% | +4.2% | +5.2% | +6.3% | +3.8% | +7.1% | +14.3% | +20.8% | +12.0% | -5.5% | +17.8% | +3.1% | +16.5% | +12.8% | +5.1% | – | |
| – | +0.0% | +80.6% | +0.0% | +23.1% | +0.0% | +25.0% | +95.2% | -38.7% | -16.2% | +20.2% | +85.8% | -19.0% | +25.4% | +17.7% | -10.5% | +12.3% | -0.8% | -1.4% | +5.1% | -5.6% | +10.0% | +3.7% | +16.4% | -2.9% | +3.0% | +19.3% | +3.0% | -0.7% | -10.9% | +2.8% | +7.9% | -8.5% | +7.2% | – | |
| – | +0.0% | +81.2% | +0.0% | +23.1% | +0.0% | +408.0% | +47.4% | -80.1% | -16.2% | +20.2% | +85.8% | -19.0% | +25.4% | +17.7% | -10.5% | +12.3% | -0.8% | -1.4% | +5.1% | -5.6% | +10.0% | +3.7% | +16.4% | -2.9% | +3.0% | +19.3% | +329.5% | -76.2% | -10.9% | +21.8% | +387.2% | +9.1% | +5.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -600.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -67.9% | +240.0% | +133.8% | +55.3% | +14.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -454.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -149.4% | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -454.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -638.6% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.